Search

everythinglearnresearchcommunity

for

Search:↓

There's no significant link between blood fat levels and male pattern baldness.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.